DaVita Inc. Files Q1 2025 10-Q
Ticker: DVA · Form: 10-Q · Filed: May 12, 2025 · CIK: 927066
| Field | Detail |
|---|---|
| Company | Davita Inc. (DVA) |
| Form Type | 10-Q |
| Filed Date | May 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, healthcare, finance, debt
TL;DR
DaVita's Q1 2025 10-Q is in. Check financials and debt.
AI Summary
DaVita Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and operational aspects of the company, which operates in the healthcare services sector, specifically focusing on kidney dialysis. Key financial figures and debt obligations are presented, alongside executive information such as James O. Hearty's role as Chief Compliance Officer.
Why It Matters
This filing provides investors and analysts with the latest financial performance and disclosures for DaVita Inc., a major provider of kidney dialysis services, impacting understanding of the company's health and market position.
Risk Assessment
Risk Level: medium — The filing contains detailed financial information, including debt obligations, which are critical for assessing the company's financial health and associated risks.
Key Numbers
- 5,000 — Shares (Likely related to share count or options, context unclear without full table.)
- 450,000 — Shares (Likely related to share count or options, context unclear without full table.)
- 77,277 — Amount (Financial figure, context unclear without full table.)
- 80,536 — Amount (Financial figure, context unclear without full table.)
- 90,770 — Amount (Financial figure, context unclear without full table.)
Key Players & Entities
- DAVITA INC. (company) — Filer of the 10-Q
- 20250331 (date) — Period of report for the 10-Q
- James O. Hearty (person) — Chief Compliance Officer
- 510354549 (company) — EIN for DaVita Inc.
- 001-14106 (company) — SEC File Number for DaVita Inc.
FAQ
What were DaVita's total revenues for the first quarter of 2025?
The provided text does not explicitly state the total revenues for the first quarter of 2025. It contains various numerical data points but lacks a clear revenue figure for the period.
What is the maturity date for the $1,250,000 debt?
The filing indicates a debt of $1,250,000 with a maturity date of 12/31/2025.
Who is James O. Hearty and what is his role?
James O. Hearty is identified as the Chief Compliance Officer for DaVita Inc.
When was DaVita Inc. formerly known as Total Renal Care Holdings Inc.?
DaVita Inc. was formerly known as Total Renal Care Holdings Inc. prior to a name change on 19950524.
What is the SEC file number for DaVita Inc.?
The SEC file number for DaVita Inc. is 001-14106.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 by James O. Hearty regarding DAVITA INC. (DVA).